Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.49% |
| 2 | Energy | 5.29% |
| 3 | Technology | 4.48% |
| 4 | Financials | 3.44% |
| 5 | Consumer Discretionary | 3.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAVM
4276
DELISTED
Cavium, Inc.
CAVM
| $301K | ﹤0.01% |
6,148
-49,535
| -89% | -$2.51M |
|
|
TIME
4277
PUT
DELISTED
Time Inc.
TIME
| $300K | ﹤0.01% |
13,020
-1,152
| -8% | -$27.7K |
|
4278
CALL
Teucrium Corn Fund
CORN
$170M
| $299K | ﹤0.01% |
13,600
+11,300
| +491% | +$291K |
|
4279
Innospec
IOSP
$2.31B
| $299K | ﹤0.01% |
8,557
-8,075
| -49% | -$328K |
|
4280
ProShares UltraPro Short QQQ
SQQQ
$1.7B
| $299K | ﹤0.01% |
1
-1
| -50% | -$382K |
|
|
EMES
4281
CALL
DELISTED
Emerge Energy Services LP
EMES
| $299K | ﹤0.01% |
+2,600
| New | +$307K |
|
4282
Agree Realty
ADC
$9.34B
| $298K | ﹤0.01% |
11,075
-295
| -3% | -$8.7K |
|
|
HTWR
4283
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $298K | ﹤0.01% |
3,864
+1,611
| +72% | +$133K |
|
4284
CALL
Innoviva
INVA
$1.53B
| $297K | ﹤0.01% |
17,500
+8,000
| +84% | +$184K |
|
4285
CALL
iShares Core S&P 500 ETF
IVV
$908B
| $297K | ﹤0.01% |
1,500
-4,100
| -73% | -$816K |
|
|
SSE
4286
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
| $297K | ﹤0.01% |
+12,933
| New | +$308K |
|
4287
Watsco Inc
WSO
$12.8B
| $296K | ﹤0.01% |
3,431
-181
| -5% | -$16.7K |
|
|
URS
4288
CALL
DELISTED
URS CORP
URS
| $296K | ﹤0.01% |
5,200
-500
| -9% | -$29K |
|
4289
CALL
Avery Dennison
AVY
$13.4B
| $295K | ﹤0.01% |
6,700
-7,500
| -53% | -$365K |
|
4290
PUT
Lazard
LAZ
$4.4B
| $295K | ﹤0.01% |
5,900
+3,900
| +195% | +$204K |
|
4291
Prothena Corp
PRTA
$459M
| $295K | ﹤0.01% |
13,496
+1,380
| +11% | +$29.3K |
|
|
QLGC
4292
DELISTED
QLOGIC CORP
QLGC
| $295K | ﹤0.01% |
32,769
-5,611
| -15% | -$53.4K |
|
|
CKP
4293
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $294K | ﹤0.01% |
24,606
-15,870
| -39% | -$210K |
|
|
BRLI
4294
CALL
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $294K | ﹤0.01% |
10,500
+3,100
| +42% | +$94.4K |
|
4295
PUT
Dana Inc
DAN
$3.26B
| $293K | ﹤0.01% |
+15,400
| New | +$350K |
|
|
4296
Innoviva
INVA
$1.53B
| $293K | ﹤0.01% |
17,217
-12,729
| -43% | -$292K |
|
4297
PUT
Wabtec
WAB
$50.7B
| $292K | ﹤0.01% |
3,600
+800
| +29% | +$66K |
|
4298
PUT
Loews
L
$23.1B
| $291K | ﹤0.01% |
+7,100
| New | +$306K |
|
4299
PUT
Allegion
ALLE
$13.9B
| $290K | ﹤0.01% |
6,171
| – | – |
|
4300
Cirrus Logic
CRUS
$6.06B
| $290K | ﹤0.01% |
14,509
-16,279
| -53% | -$377K |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.5% of assets, up from 5% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.